Delivery Order SPE2DB22D3016-SPE2DB25FADS5

Award Date 11/18/24
Potential Completion Date 12/10/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FASD0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,083.75 firm fixed-price delivery order is for the supply of 4567682283 TIVDAK 40 MG VIALS. The contract has an ultimate completion date of April 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of pharmaceutical products, including the drug TIVDAK 40 MG VIALS. The award has a ceiling value of $27,898.01 and a completion date of November 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of TIVDAK 40 MG VIALS, a pharmaceutical product, to support military healthcare programs. The $13,083.75 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $11,956.29 firm fixed-price delivery order is for the supply of 40 mg vials of the drug TIVDAK. The contract does not have a set-aside designation and has an ultimate completion date of July 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVM13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,083.75 firm fixed-price delivery order is for the supply of 4,568,078,648 units of the drug TIVDAK 40 MG VIALS. The contract has a period of performance through May 20, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for $40,134.64. The delivery order contract has an ultimate completion date of November 22, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,277.26 Firm Fixed Price Delivery Order contract has an ultimate completion date of January 3, 2023 and covers the procurement of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,591.90 firm fixed-price delivery order contract has a completion date of March 4, 2025 and does not utilize any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,083.75, is for the delivery of 40 mg vials of the drug TIVDAK. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,606.50 firm fixed-price delivery order contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FADS5
    Delivery Order

This federal contract award (SPE2DB22D3016|SPE2DB25FADS5) was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,956.29 firm fixed-price delivery order is for the supply of TIVDAK 40 MG VIALS medical product. The contract has an ultimate completion date of December 10, 2024.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The current award was not designated with any set-aside requirements, indicating open competition.

Generated 5/20/25, 2:22 PM